FloodLAMP Biotechnologies PBC Revenue and Competitors
Estimated Revenue & Valuation
- FloodLAMP Biotechnologies PBC's estimated annual revenue is currently $775k per year.
- FloodLAMP Biotechnologies PBC's estimated revenue per employee is $155,000
Employee Data
- FloodLAMP Biotechnologies PBC has 5 Employees.
- FloodLAMP Biotechnologies PBC grew their employee count by -29% last year.
FloodLAMP Biotechnologies PBC's People
Name | Title | Email/Phone |
---|---|---|
1 | Design, Strategy, Communications | Reveal Email/Phone |
2 | Lab Assistant | Reveal Email/Phone |
FloodLAMP Biotechnologies PBC Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is FloodLAMP Biotechnologies PBC?
FloodLAMP is developing a cooperative, open approach to revolutionize diagnostics in service of the greatest positive impact on the COVID crisis and public health, both nationally and globally. Our program is designed to repeatedly screen interacting groups through molecular tests that: - cost less than $1 per person; - enable a single basic lab to screen 50,000 people/day; - have high sensitivity to reliably identify new infections early; - minimize spread and stops outbreaks; - drive down disease prevalence, enabling a return to economic growth and a thriving society.
keywords:N/AN/A
Total Funding
5
Number of Employees
$775k
Revenue (est)
-29%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.4M | 5 | 150% | N/A |
#2 | $0.8M | 5 | -44% | N/A |
#3 | $0.4M | 5 | -58% | N/A |
#4 | N/A | 5 | -97% | N/A |
#5 | $0.8M | 5 | -17% | N/A |